NCT04389632 2026-03-16A Study of Sigvotatug Vedotin in Advanced Solid TumorsSeagen Inc.Phase 1 Recruiting1,006 enrolled
NCT06607185 2026-03-13A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid TumorsEli Lilly and CompanyPhase 1 Active not recruiting750 enrolled
NCT03174275 2026-02-23Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and Neck Squamous Cell CarcinomaUNC Lineberger Comprehensive Cancer CenterPhase 2 Active not recruiting39 enrolled 8 charts
NCT04229459 2026-01-14Trial of Nivolumab and Cetuximab After Chemoradiation in Esophageal Squamous Cell Carcinoma Patients.Rabin Medical CenterPhase 2 Active not recruiting12 enrolled
NCT06676449 2026-01-07TDLN-sparing RT Plus Immunotherapy and Chemotherapy in Locally Advanced ESCCFudan UniversityPhase 3 Recruiting432 enrolled
NCT05945823 2025-12-29Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid TumorsTaiho Oncology, Inc.Phase 2 Active not recruiting53 enrolled